Cargando…
High fever following postpartum administration of sublingual misoprostol
OBJECTIVE: To explore what triggers an elevated body temperature of ≥40.0°C in some women given misoprostol, a prostaglandin E1 analogue, for postpartum haemorrhage (PPH). DESIGN: Post hoc analysis. SETTING: One tertiary-level hospital in Quito, Ecuador. POPULATION: A cohort of 58 women with a fever...
Autores principales: | Durocher, J, Bynum, J, León, W, Barrera, G, Winikoff, B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878599/ https://www.ncbi.nlm.nih.gov/pubmed/20406228 http://dx.doi.org/10.1111/j.1471-0528.2010.02564.x |
Ejemplares similares
-
Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012) -
Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial
por: Mobeen, N, et al.
Publicado: (2011) -
High fever after sublingual administration of misoprostol for treatment of post‐partum haemorrhage: a hospital‐based, prospective observational study in Argentina
por: Durocher, Jill, et al.
Publicado: (2020) -
A Comparative Study of Sublingual Misoprostol Versus Intramuscular Oxytocin in the Active Management of Third Stage of Labor
por: Mishra, Shweta, et al.
Publicado: (2023) -
Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostol
por: Ditai, James, et al.
Publicado: (2017)